Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. 2005

Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario N6A 5C1, Canada.

Various cardiovascular pathologies are associated with vascular smooth muscle cell (VSMC) hypertrophy and elevated plasma leptin levels. We used the rat portal vein (RPV) cultured for three days to investigate the effect of mechanical stretch on autocrine secretion of leptin and the effect of exogenous leptin (3.1 nM) on VSMC. Stretching the RPV significantly up-regulated leptin production by greater than 100-fold and leptin receptor expression by up to 10-fold. In addition, stretch increased tissue weight by 23 +/- 1.3 and 30 +/- 1% (P < 0.05), respectively, in the absence or presence of leptin, although this was significantly attenuated by an antileptin antibody (166 ng/ml). Unstretched RPV weight decreased by 7.5 +/- 1.8% in the absence of leptin, whereas in the presence of leptin, weight increased by 6.5 +/- 1.8% (P < 0.05). VSMC size and [3H]leucine incorporation rates were significantly increased by leptin in stretched and unstretched tissues. Leptin-induced hypertrophy was associated with significant extracellular signal-regulated kinase (ERK1/2) activation as well as increased expression of angiotensinogen, the angiotensin type 1 receptor as well as preproendothelin-1, and the endothelin type A receptor, whereas ERK inhibition or inhibition of either the angiotensin II or endothelin-1 systems at both the synthesis and receptor levels blocked the hypertrophic response. The effects of leptin were also completely blocked by the cholesterol-chelating agent methyl-beta-cyclodextrin. Therefore, our study demonstrates stretch-dependent leptin release and a direct hypertrophic effect of leptin on RPV, the latter likely dependent on intact cholesterol-rich membrane microdomains and locally produced paracrine factors.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
January 2009, Journal of the American Society of Hypertension : JASH,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
April 2001, Journal of hypertension,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
January 2010, Mediators of inflammation,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
February 2011, Acta biochimica et biophysica Sinica,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
June 2004, Journal of hypertension,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
February 1993, Journal of cellular physiology,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
September 2006, Arteriosclerosis, thrombosis, and vascular biology,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
October 2006, Experimental & molecular medicine,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
January 2014, Hypertension research : official journal of the Japanese Society of Hypertension,
Asad Zeidan, and Daniel M Purdham, and Venkatesh Rajapurohitam, and Sabzali Javadov, and Subrata Chakrabarti, and Morris Karmazyn
December 2001, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!